Selected research
Industry Research
Inhaled Corticosteroid Industry Research Report 2026
Market perspective
The global Inhaled Corticosteroid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inhaled Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inhaled Corticosteroid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inhaled Corticosteroid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inhaled Corticosteroid include Teva Pharmaceutical, Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GSK, Amgen and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inhaled Corticosteroid market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhaled Corticosteroid Market by Company
Teva Pharmaceutical
Sanofi
Johnson and Johnson
Novartis
Merck
Pfizer
GSK
Amgen
AstraZeneca
Teijin
Sumitomo
Kos Pharmaceutical
Glaxo's Advair
Inhaled Corticosteroid Segment by Type
Mometasone
Fluticasone Inhaler Powder
Budesonide
Beclomethasone Dipropionate
Others
Inhaled Corticosteroid Segment by Application
Respiratory Care Centers
Hospitals
Clinics
Others
Inhaled Corticosteroid Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Corticosteroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhaled Corticosteroid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Corticosteroid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inhaled Corticosteroid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inhaled Corticosteroid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inhaled Corticosteroid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mometasone
- Fluticasone Inhaler Powder
- Budesonide
- Beclomethasone Dipropionate
- Others
Applications
- Respiratory Care Centers
- Hospitals
- Clinics
- Others
Companies covered
- Teva Pharmaceutical
- Sanofi
- Johnson and Johnson
- Novartis
- Merck
- Pfizer
- GSK
- Amgen
- AstraZeneca
- Teijin
- Sumitomo
- Kos Pharmaceutical
- Glaxo's Advair
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Inhaled Corticosteroid Market Size (2021-2032)
- 2.2.2 Global Inhaled Corticosteroid Sales (2021-2032)
- 2.2.3 Global Inhaled Corticosteroid Market Average Price (2021-2032)
- 2.3 Inhaled Corticosteroid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mometasone
- 2.3.3 Fluticasone Inhaler Powder
- 2.3.4 Budesonide
- 2.3.5 Beclomethasone Dipropionate
- 2.3.6 Others
- 2.4 Inhaled Corticosteroid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Respiratory Care Centers
- 2.4.3 Hospitals
- 2.4.4 Clinics
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inhaled Corticosteroid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Inhaled Corticosteroid Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Inhaled Corticosteroid Revenue of Manufacturers (2021-2026)
- 3.4 Global Inhaled Corticosteroid Average Price by Manufacturers (2021-2026)
- 3.5 Global Inhaled Corticosteroid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Inhaled Corticosteroid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Inhaled Corticosteroid, Product Type & Application
- 3.8 Global Manufacturers of Inhaled Corticosteroid, Established Date
- 3.9 Global Inhaled Corticosteroid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Inhaled Corticosteroid Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Inhaled Corticosteroid Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Johnson and Johnson
- 4.3.1 Johnson and Johnson Company Information
- 4.3.2 Johnson and Johnson Business Overview
- 4.3.3 Johnson and Johnson Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson and Johnson Inhaled Corticosteroid Product Portfolio
- 4.3.5 Johnson and Johnson Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Inhaled Corticosteroid Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Inhaled Corticosteroid Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Inhaled Corticosteroid Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Inhaled Corticosteroid Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Amgen
- 4.8.1 Amgen Company Information
- 4.8.2 Amgen Business Overview
- 4.8.3 Amgen Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Amgen Inhaled Corticosteroid Product Portfolio
- 4.8.5 Amgen Recent Developments
- 4.9 AstraZeneca
- 4.9.1 AstraZeneca Company Information
- 4.9.2 AstraZeneca Business Overview
- 4.9.3 AstraZeneca Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AstraZeneca Inhaled Corticosteroid Product Portfolio
- 4.9.5 AstraZeneca Recent Developments
- 4.10 Teijin
- 4.10.1 Teijin Company Information
- 4.10.2 Teijin Business Overview
- 4.10.3 Teijin Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teijin Inhaled Corticosteroid Product Portfolio
- 4.10.5 Teijin Recent Developments
- 4.11 Sumitomo
- 4.11.1 Sumitomo Company Information
- 4.11.2 Sumitomo Business Overview
- 4.11.3 Sumitomo Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sumitomo Inhaled Corticosteroid Product Portfolio
- 4.11.5 Sumitomo Recent Developments
- 4.12 Kos Pharmaceutical
- 4.12.1 Kos Pharmaceutical Company Information
- 4.12.2 Kos Pharmaceutical Business Overview
- 4.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Kos Pharmaceutical Inhaled Corticosteroid Product Portfolio
- 4.12.5 Kos Pharmaceutical Recent Developments
- 4.13 Glaxo's Advair
- 4.13.1 Glaxo's Advair Company Information
- 4.13.2 Glaxo's Advair Business Overview
- 4.13.3 Glaxo's Advair Inhaled Corticosteroid Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Glaxo's Advair Inhaled Corticosteroid Product Portfolio
- 4.13.5 Glaxo's Advair Recent Developments
5 Global Inhaled Corticosteroid Market Scenario by Region
- 5.1 Global Inhaled Corticosteroid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inhaled Corticosteroid Sales by Region: 2021-2032
- 5.2.1 Global Inhaled Corticosteroid Sales by Region: 2021-2026
- 5.2.2 Global Inhaled Corticosteroid Sales by Region: 2027-2032
- 5.3 Global Inhaled Corticosteroid Revenue by Region: 2021-2032
- 5.3.1 Global Inhaled Corticosteroid Revenue by Region: 2021-2026
- 5.3.2 Global Inhaled Corticosteroid Revenue by Region: 2027-2032
- 5.4 North America Inhaled Corticosteroid Market Facts & Figures by Country
- 5.4.1 North America Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Inhaled Corticosteroid Sales by Country (2021-2032)
- 5.4.3 North America Inhaled Corticosteroid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Inhaled Corticosteroid Market Facts & Figures by Country
- 5.5.1 Europe Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Inhaled Corticosteroid Sales by Country (2021-2032)
- 5.5.3 Europe Inhaled Corticosteroid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Inhaled Corticosteroid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Inhaled Corticosteroid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Inhaled Corticosteroid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Inhaled Corticosteroid Market Facts & Figures by Country
- 5.7.1 South America Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Inhaled Corticosteroid Sales by Country (2021-2032)
- 5.7.3 South America Inhaled Corticosteroid Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Inhaled Corticosteroid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Inhaled Corticosteroid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Inhaled Corticosteroid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Inhaled Corticosteroid Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Inhaled Corticosteroid Sales by Type (2021-2032)
- 6.1.1 Global Inhaled Corticosteroid Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Inhaled Corticosteroid Sales Market Share by Type (2021-2032)
- 6.2 Global Inhaled Corticosteroid Revenue by Type (2021-2032)
- 6.2.1 Global Inhaled Corticosteroid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Inhaled Corticosteroid Revenue Market Share by Type (2021-2032)
- 6.3 Global Inhaled Corticosteroid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Inhaled Corticosteroid Sales by Application (2021-2032)
- 7.1.1 Global Inhaled Corticosteroid Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Inhaled Corticosteroid Sales Market Share by Application (2021-2032)
- 7.2 Global Inhaled Corticosteroid Revenue by Application (2021-2032)
- 7.2.1 Global Inhaled Corticosteroid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Inhaled Corticosteroid Revenue Market Share by Application (2021-2032)
- 7.3 Global Inhaled Corticosteroid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Inhaled Corticosteroid Value Chain Analysis
- 8.1.1 Inhaled Corticosteroid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Inhaled Corticosteroid Production Mode & Process
- 8.2 Inhaled Corticosteroid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Inhaled Corticosteroid Distributors
- 8.2.3 Inhaled Corticosteroid Customers
9 Global Inhaled Corticosteroid Analyzing Market Dynamics
- 9.1 Inhaled Corticosteroid Industry Trends
- 9.2 Inhaled Corticosteroid Industry Drivers
- 9.3 Inhaled Corticosteroid Industry Opportunities and Challenges
- 9.4 Inhaled Corticosteroid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst